Venugopalan Named SPIE Fellow

By Lori Brandt, UC Irvine Samueli School of Engineering

Feb. 26, 2026 –SPIE, the international society for optics and photonics, has recognized Vasan Venugopalan, as one of 40 new fellows in 2026. Venugopalan is chair and professor of chemical and biomolecular engineering at UC Irvine. SPIE fellows are selected for making significant scientific and technical contributions in the multidisciplinary fields of optics, photonics and imaging. Venugopalan has achieved pioneering innovations in three research areas of biophotonics: laser ablation of biological tissues, pulsed laser microbeam interactions with cells, and computational biophotonics and dissemination of open-source software.

He also has made exceptional contributions in developing and implementing novel and impactful educational programs to support multidisciplinary training of students, researchers and industrial professionals in the area of biophotonics. His contributions have had tangible benefits for both UCI Ph.D. students across campus — impacting the Schools of Engineering, Physical Sciences, Biological Sciences and Medicine — as well as a larger population of academic and industrial researchers nationally and internationally.

Venugopalan’s efforts have resulted in the development of five extramurally funded ($6.5 million in total) multidisciplinary educational initiatives, each utilizing mixed methods, for intensive research education and training, coupled with professional development and technical and career mentorship. Examples include an NSF Integrated Graduate Education, Research and Training (IGERT) program, several NIH short courses and training programs in computational and biophotonics, and a UC/HBCU program for multidisciplinary research experience for undergraduate students.

“I’m tremendously honored to be recognized in this way and join a group of colleagues whose contributions and accomplishments I deeply respect,” said Venugopalan. His election was recognized in January at the Annual Fellows Luncheon at SPIE’s Photonics West Conference, the world’s largest conference in the field of optics and photonics.

Since SPIE’s inception in 1955, more than 1,800 SPIE members have become fellows.

Click here or visit https://bit.ly/vasan-named-spie to read full article on the UC Irvine Samueli School of Engineering website.

 

A laser focus on melanoma

Mihaela Balu and her team develop skin scanner that can better detect early signs of deadly cancer

When Mihaela Balu was interviewing for a postdoctoral position nearly two decades ago, she would describe the kind of training she was looking for, and nearly everyone she talked to nationwide said, “You should go to Beckman Laser Institute & Medical Clinic.” Fortunately for UC Irvine, she did.

Now an associate professor of dermatology and biomedical engineering, Balu and her team have developed a device that uses a low-power infrared laser to scan beneath the skin surface at a cellular level. The goal is to better detect early signs of melanoma – without biopsy – and to monitor the effectiveness of skin treatments. Balu has received several National Institutes of Health grants as well as funding from the Department of Defense: “They have soldiers in the field exposed to sun,” she notes.

With the device now in clinical trials, Balu says that none of this could have happened without federal support. “Those grants give us the ability to attract the best talent, and it’s important to have talented, passionate, dedicated people driving the research,” she says.

The competition for top-quality researchers is fierce, as private industry can offer better compensation. “I’m very fortunate to work with an exceptional team,” Balu says. “Within our larger group, we have a core set of people whose expertise is essential to our long-term success. It’s important to retain that core. We don’t want to hire talented people for a few years, lose funding and be forced to rebuild. Our goal is to maintain a stable foundation.”

Balu, a physicist and engineer by training, leads a team that includes two other physicists, a biologist, a chemist and a biomedical engineer. This broad range of skills is powerful in a setting where research shares the clinical space, something she notes is extremely rare.

“It allows us to track the performance of the devices we build, evaluate their limitations and get them back to the lab for design improvements,” she says.

The device – known as the fast, large-area, multiphoton exoscope – is wheeled into a clinical research room and connected to a small metal ring taped to a patient’s skin to ensure stability. A laser is used to excite molecules, allowing the FLAME to form detailed images of the cells and fibers underneath.

“The scan takes about 10 to 15 minutes right now, but the team is striving to shorten it to 5,” Balu says. “We don’t have technicians running studies; we run the devices on patients ourselves. It’s the only way to understand what needs to be improved.”

The goal? Being able to diagnose skin conditions without cutting and to monitor the success of various therapies, specifically immunotherapies for metastatic melanoma.

“We’re tracking the response at a cellular level to see when treatment is working or not,” Balu says. “That allows us to give feedback so therapies can be tailored to each individual.”

This means that patients make fewer trips to the doctor and get earlier detection and more specific treatment plans.

This year, Balu’s team is moving the device into new space on the recently completed UCI Health — Irvine campus.

“When I first started bringing complex technology like this into the clinic, we were squeezed into a storage room,” she says. “And now we’ll have two research rooms in the new building. That’s success for me.”

It’s this federally funded research and much more like it that keep UC Irvine moving forward and advancing its status. The campus has been ranked as one of the top 10 public universities in the country for more than a decade.

“I feel fortunate to have the opportunity to build my work and my career here,” Balu says. “I love the multidisciplinary culture and collaborative environment.”

Click here or visit https://bit.ly/balu-laser-focus to read full UC Irvine News article.

Click here or visit https://bit.ly/balu-laser-focus-video to watch video on the ucirvine YouTube channel.

Commercialization in Biophotonics: A conversation with David Cuccia and Amaan Mazhar about Modulim

Biophotonics Discovery: The Podcast

In this episode of our commercialization series, Darren and Gwen sit down with David Cuccia (President & CTO) and Amaan Mazhar (CEO) of Modulim, a biophotonics startup developing commercial applications of Spatial Frequency Domain Imaging (SFDI).

David and Amaan share their journey from graduate school at UC Irvine’s Beckman Laser Institute to building a medtech company. The conversation covers practical lessons about FDA regulatory pathways, the importance of quality systems, and how they’re addressing diabetic complications and amputations through tissue oxygenation measurements. They also share valuable insights about finding the right early adopter customers, adapting product form factors based on clinical feedback, and understanding that in medtech, you have multiple “customers”—from the FDA to insurance companies to physicians.

Whether you’re a researcher considering commercialization or simply curious about the path from lab to market, this episode offers an honest, detailed look at building a biophotonics startup.

Click here or visit https://bit.ly/biophotonicspod to listen to the “Biophotonics Discovery: The Podcast” episode.

Howard Lee selected as Moore Experimental Physics Investigator to Develop Revolutionary Nanoscale Electron Accelerator

Professor Howard Lee in the UC Irvine Department of Physics & Astronomy has been named a 2025 Experimental Physics Investigator by the Gordon and Betty Moore Foundation. The funding will support Lee in advancing groundbreaking research in nanoscale electron acceleration technology. Lee is developing the world’s first nanoscale electron accelerator by merging advanced nano-optical materials and nanostructures with laser wakefield acceleration. Unlike traditional accelerators such as the Large Hadron Collider that require extensive long well-defined channels, Lee’s apparatus uses nanoscale solid-state materials and high-power ultrafast lasers to accelerate electrons and generate X-rays.

“This award is significant since it allows me to pursue an entirely new research direction not previously explored,” Lee said. “Given the current funding climate, the opportunity to support research with bold new ideas is truly game-changing for my group, allowing us to further advance optical science and technology. I am deeply grateful to the Moore Foundation for their generous support.” Lee’s work could enable new medical therapies, including laser wakefield accelerator optical fiber endoscope probes and free electron laser devices for next-generation biomedical and imaging technologies. When integrated into optical fibers, these nanoscale accelerators could open transformative biomedical applications, including advanced cancer treatments.

Click here or visit https://heyzine.com/flip-book/2025SoPS#page/1 to read the full article in the 2025 UC Irvine School of Physical Sciences Deans Report.

2025 NSF Graduate Research Fellows

Eight students from the UC Irvine School of Physical Sciences received the prestigious 2025 National Science Foundation Graduate Research Fellowship (NSF GRFP) award. The fellowship is a five-year program that provides full financial support for three years, and it recognizes outstanding students pursuing research in STEM graduate programs.

“Not only do they pursue research in innovative and impactful fields, but they also perform a broad range of mentorship and training efforts aimed at lifting up those around them. When the nation funds these students, they are investing in the hundreds of other people that these students engage with as well.”
– Franklin Dollar, Associate Dean of Graduate Studies and professor in the UC Irvine Department of Physics & Astronomy

2025 UC IRVINE NSF GRFP RECIPIENTS

Massee Akbar – Physics & Astronomy

Massee Akbar graduated with his bachelor’s in physics from the UC Irvine Department of Physics & Astronomy this June and is beginning a Ph.D. this fall in the lab of Professor Howard Lee. With NSF support, Akbar is developing next-generation nanophotonic optical fibers—microscopes as thin as a human hair—by 3D-printing patterns onto fiber tips to control light without bulky lenses. The technology could one day make minimally invasive medical imaging possible.

Click here or visit https://heyzine.com/flip-book/2025SoPS#page/1 to read the full article in the 2025 UC Irvine School of Physical Sciences Deans Report.

UCI Health celebrates more than 215 Physicians of Excellence

Leaders in their specialty chosen by the Orange County Medical Association; more than any other OC health system

Orange, Calif. — More than 215 UCI Health doctors have been recognized as 2026 Physicians of Excellence by the Orange County Medical Association (OCMA), more than any other health system in the region.

OCMA’s Physician of Excellence program, now in its 22nd year, honors physicians in Orange County who have exhibited the skills, training and commitment to their patients and the community to stand above their peers as physicians of excellence.

The complete list, published in the January 2026 issue of Orange Coast Magazine, includes nearly 700 Orange County physicians across about 75 clinical specialties.

OCMA is regarded as having a fair and unbiased process for selecting Physicians of Excellence awardees. To be eligible for recognition, physicians are required to:

  • Be certified by a member board within the American Board of Medical Specialties, the American Board of Osteopathic Medical Specialties or an equivalent board recognized by the Medical Board of California or the Osteopathic Medical Board of California
  • Be in good standing with the Medical Board of California or Osteopathic Medical Board of California
  • Have maintained their primary practice in Orange County for the last five years
  • Have practiced within their specialty for the last five years

Doctors also are required to demonstrate achievements in at least two of the following criteria: physician leadership; teaching/mentoring; medical research/scientific advances; humanitarian service and unique contributions in community service.

UCI Health is proud to recognize our more than 215 UCI Health doctors named 2026 Physicians of Excellence. The compassionate, expert care they provide helps us deliver on our promise of a healthier tomorrow for our patients and our community as a whole.

2026 UCI Health Physicians of Excellence

Allergy
Donald S. Levy, MD

Anesthesiology
Kyle Ahn, MD
Melissa Chang, MD
Robert R. Field, MD
Kimberly M. Gimenez, MD
Anna L. Harris, MD
Richard J. Kelly, MD
Debra E. Morrison, MD
Ariana M. Nelson, MD
Kyle Parades, MD
Lynnus Peng, MD
Ramin Rahimian, MD
Anil Tiwari, MD
Trung Vu, MD
Gregory Yoshikawa, MD

Cardiovascular disease
Ailin Barseghian El-Farra, MD
Roxana Ghashghaei, MD
Jin Kyung Kim, MD, PhD
Ali Naqvi, MD
Pranav M. Patel, MD

Dermatology
Linda T. Doan, MD
Kristen M. Kelly, MD
Bonnie A. Lee, MD
Patrick K. Lee, MD
Natasha Mesinkovska, MD
Melissa L. Shive, MD
Janellen Smith, MD

Diagnostic radiology
Arash Anavim, MD
Joseph E. Burns, MD
Hyung Won Choi, MD
Maryam Golshan-Momeni, MD
Mohammad Helmy, MD
Roozbeh Houshyar, MD
Rony Kampalath, MD
Edward, Kuoy, MD
Irene S. Tsai, MD
Marisa Tseng, MD
Vahid Yaghmai, MD
Jennifer J. Young, MD

Emergency medicine
Patrick Aguilera, MD
Carrie Chandwani, MD
Heesun Choi, DO
Timothy Korber, MD
Mark I. Langdorf, MD
Megan Boysen Osborn, MD
Ronald J. Rivera, MD
Lindsay C. Spiegelman, MD
Alisa V. Wray, MD

Facial plastic & reconstructive surgery
Brian J.F. Wong, MD

Family medicine
Tan Q. Nguyen, MD
Andrew S. Nobe, MD
Baotran N. Vo, MD

Gastroenterology
C. Gregory Albers, MD
Ke-Qin Hu, MD
John G. Lee, MD
Christina Ling, MD
Nimisha K. Parekh, MD
Sandra Sunhee Park, MD
Jason B. Samarasena, MD

Geriatric medicine
Elham Arghami, MD
Lisa M. Gibbs, MD
Sonia R. Sehgal, MD
Steven P. Tam, MD

Gynecologic oncology
Krishnansu Tewari, MD
Jill Tseng, MD

Hematology-oncology
Elizabeth A. Brém, MD
Stefan O. Ciurea, MD
Deepa Jeyakumar, MD
Edward L. Nelson, MD
Zahra Pakbaz, MD
Lauren Pinter-Brown, MD
Richard A. Van Etten, MD, PhD

Hospice/palliative care
Shiho Ito, MD

Internal Medicine
Alpesh Amin, MD, MBA
Emilie L. Chow, MD
Sonali Iyer, MD
Bavani Nadeswaran, MD
Hoang Anh Nguyen, MD
Maryam Rahimi, MD
Virgil S. Raymundo, MD
Bobby Sasson, MD
Interventional radiology
Nadine Abi-Jaoudeh, MD
Dayantha M. Fernando, MDMaternal-fetal medicine
Judith H. Chung, MD, PhD
Afshan Hameed, MD
Tamera J. Hatfield, MD, PhD
Jennifer A. Jolley, MD
Carol Major, MD
Manuel Porto, MD
Jonathan G. Steller, MD

Medical oncology
Farshid Dayyani, MD, PhD
Nataliya Mar, MD
Arash Rezazadeh Kalebasty, MD
Jason A. Zell, DO

Neonatal-perinatal medicine
Muhammad Aslam, MD
Fayez Bany-Mohammed, MD
Rebecca J. Coleman, MD
Cherry Uy, MD

Neurodevelopmental disorders
Peter Chung, MD
Thusa Sabapathy, MD

Neurology
Yama Akbari, MD, PhD
Sanaz Attaripour Isfahani, MD
Mark J. Fisher, MD
Namita A. Goyal, MD
Xiao-Tang Kong, MD, PhD
Lilit Mnatsakanyan, MD
Tahseen Mozaffar, MD
Mona Sazgar, MD

Nephrology
Anthony Ferrey, MD
Ramy Hanna, MD
Wei Ling Lau, MD
Uttam Reddy, MD
Ekamol Tantisattamo, MD

Neurosurgery
Jefferson Chen, MD, PhD
Kiarash Golshani, MD
Frank P.K. Hsu, MD, PhD
Mark E. Linskey, MD
Michael Y. Oh, MD
Michelle Paff, MD
Sumeet Vadera, MD

Nuclear medicine
Sindu Alexander, MD

Obstetrics & gynecology
Donna Baick, MD
Jennifer Butler, MD
Nkiruka Chuba, MD
Tabetha R. Harken, MD
Christine Kim, MD
Michael L Krychman, MD
Jasmine Patel, MD
Rachel Perry, MD
Rebecca M. Sauer, MD

Occupational health
Scott E. Hardy, MD

Ophthalmology
Andrew W. Browne, MD
Robert W. Crow, MD
Lilangi S. Ediriwickrema, MD
Marjan Farid, MD
Sumit (Sam) Garg, MD
Charlotte Gore, MD
Sanjay Kedhar, MD
Baruch D. Kuppermann, MD, PhD
Ken Y. Lin, MD
Stephanie Y. Lu, MD
Mitul C. Mehta, MD
Sameh Mosaed, MD
Jeremiah P. Tao, MD
Matthew W. Wade, MD

Orthopaedic surgery
Nitin N. Bhatia, MD
Andrew R. Hsu, MD
Yu-Po Lee, MD
John A. Scolaro, MD
Russell N. Stitzlein, MD
Dean Wang, MD 

Otolaryngology/Head & Neck Surgery
William B. Armstrong, MD
Naveen D. Bhandarkar, MD
Hamid R. Djalilian, MD
Edward C. Kuan, MD
Sepehr Oliaei, MD
Tjoson Tjoa, MD

Pathology
Cassiana E. Bittencourt, MD
Julio A. Ibarra, MD

Pediatrics
Behnoosh Afghani, MD
Amy Cheng, MD
Melitza Cobham-Browne, MD
Elsie Rosso Hidalgo, MD
Leticia C. Oliveros, MD
Candice E. Taylor, MD

Pediatric medical genetics
June-Anne Gold, MD
Virginia Kimonis, MD

Pediatric radiology
Liliane Gibbs, MD

Pediatric urology
Kai-wen Chuang, MD
Heidi A. Stephany, MD
Elias Wehbi, MD

Physical medicine & rehabilitation
Danielle Perret Karimi, MD
David W. Lee, MD

Plastic surgery
Gregory R.D. Evans, MD
Daniel Jaffurs, MD

Psychiatry
Rimal B. Bera, MD
John Luo, MD
Robert McCarron, DO

Pulmonary disease
Richard A. Lee, MD

Rheumatology
Sheetal Desai, MD
Alan Schenk, MD

Surgery
Cristobal Barrios Jr., MD
Joseph C. Carmichael, MD
Shaun Daly, MD
Marcelo W. Hinojosa, MD
David K. Imagawa, MD, PhD
Zelijka Jutric, MD
Kari Kansal, MD
Karen T. Lane, MD
Melissa L. Mao, MD
Jeffry T. Nahmias, MD
Ninh T. Nguyen, MD
Brian R. Smith, MD

Thoracic surgery
Ali Mahtabifard, MD

Transfusion medicine
Minh-Ha Tran, DO

Urogynecology
Taylor Brueseke, MD
Felicia L. Lane, MD
Dena E. Moskowitz, MD

Urology
Ralph V. Clayman, MD
Joel Gelman, MD
Gamal M. Ghoniem, MD
Greg E. Gin, MD
Pengbo, Jiang, MD
Mark L. Jordan, MD
Jaime Landman, MD
Ross Moskowitz, MD
Roshan M. Patel, MD
M. Leon Seard II, MD
Edward Uchio, MD
Faysal A. Yafi, MD

Vascular surgery
Anthony H. Chau, MD
Samuel L. Chen, MD
Roy M. Fujitani, MD
Nii-Kabu Kabutey, MD
Isabella J. Kuo, MD

About UCI Health
UCI Health, one of California’s largest academic health systems, is the clinical enterprise of the University of California, Irvine. The 1,461-bed system comprises its main campus UCI Health — Orange, its flagship hospital, the UCI Health — Irvine acute care hospital and medical campus, four hospitals and affiliated physicians of the UCI Health Community Network in Orange and Los Angeles counties and a network of ambulatory care centers across the region. UCI Health — Orange provides tertiary and quaternary care and is home to the only Orange County-based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. Powered by UC Irvine, UCI Health serves 5.6 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us on Facebook, Instagram, LinkedIn and X (formerly Twitter).

Click here to read full article on UCI Health News.

Institute Investigators Receive NHLBI Catalyze Program Grant to Develop Maternal Health Monitoring Technology

UC Irvine Beckman Laser Institute & Medical Clinic researchers Drs. Bernard Choi and Michelle Khine have been awarded a $1.2 million grant from the National Heart, Lung, and Blood Institute (NHLBI) for the project, “Maternal Obstetric Monitoring System (MOMS): a Postpartum Hemorrhage (PPH) Wearable Monitor.”  This award brings the researchers into the NHLBI’s Catalyze Program, a comprehensive translational research support mechanism that provides funding, project management, technical services, and commercialization guidance designed to accelerate the translation of new therapies, devices, and diagnostics to market.

The project aims to develop MOMS, a technology designed to improve early detection of postpartum hemorrhage (PPH), a leading cause of maternal death. By continuously monitoring vital signs, measuring high-quality physiological waveforms, and performing advanced analysis of the measurements, MOMS seeks to identify significant blood loss in new mothers more effectively than current methods, potentially saving lives and improving maternal health outcomes.

The multidisciplinary team – comprising experts in biomedical engineering, obstetrics & gynecology, sociology, and data science – will create a miniaturized, wearable device integrated with multiple sensors.  The device will simultaneously measure continuous blood pressure, heart rate, cardiac output, stroke volume, blood flow, hemoglobin oxygen saturation, and oxygen utilization to facilitate early detection of hypovolemia, or insufficient blood circulation.

The project will deliver a uniquely comprehensive hemodynamic and hemorrhage monitor specifically designed for PPH detection. The team will first finalize their alpha prototype and conduct preliminary validation. The next phase involves refining the technology to create a low-profile, user-friendly beta prototype based on end-user requirements and validated through testing on a diverse population. Data collected will inform predictive algorithm development, culminating in a pilot study with pregnant women during and after delivery.

Upon successful completion, the validated MOMS sensor technology will be ready for both hospital and ambulatory monitoring use during delivery and postpartum care.  MOMS will provide more accurate, precise and robust early indicators of PPH than commercially available technologies, ultimately improving maternal survival rates.

NHLBI’s Catalyze Program enables and expedites the translation of basic science discoveries into new treatments, devices, and diagnostics for patients with heart, lung, blood, and sleep disorders (HLBS).  The program advances potential new medical products through development to the preclinical testing stage by providing research funding, mentoring, advisory services, technology development guidance, regulatory affairs support, commercialization assistance, skills development and education.

About Catalyze

Catalyze’s mission is to provide comprehensive support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates cleared for human testing, while developing a translational research workforce fluent in product development and entrepreneurship.  The organization’s strategies include, funding for HLBS-related therapies, and diagnostics across the translational continuum; supporting scientists in setting achievable milestones that advance projects along the research pathway, educating investigators in translation, marketing, and product commercialization; anticipating researcher needs so they can focus on science rather than project administration; and pivoting funding and support quickly based on evolving project and scientific requirements.

Click here to learn more about Catalyze.

The research described above is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

Here’s why your hair turns gray, and what you can do about it

Genetics and age shape the process, but you may have some control over it, too.

By Kathleen Felton, The Washington Post

Whether you’re embracing new silver growths or attacking them strand by strand with tweezers, gray hair is an inevitable part of getting older. “Just as the skin ages and the rest of the organs in your body age, the hair ages, too,” said Helen He, an assistant professor in the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai.

The going-gray process happens at different speeds for different people, she said, but most of us start to notice increasing gray hair sometime in our 30s or 40s, according to the American Academy of Dermatology. Around this time, melanocyte stem cells, which are hair follicle cells responsible for depositing pigment into the hair shaft, can start to become depleted or dysfunctional.

“There’s not really a whole lot known about why the melanocyte stem cells die off,” said George Cotsarelis, chair of the dermatology department at the Perelman School of Medicine at the University of Pennsylvania and a hair-follicle stem-cell researcher. But there are a number of reasons, including stress or DNA damage, “that are thought to maybe prevent these stem cells from surviving,” he said.

The process, called cellular senescence, causes hair to “gradually lose its pigment over time,” He said. Strands that previously were black, brown, red or blond start to emerge from the follicle gray or silver-white. Some people also notice that their gray hair has a coarser texture.

Age remains a major predictor of when a person is likely to go gray. One 2012 study of more than 4,000 participants found that between ages 45 and 65, nearly three-quarters were at least partially gray. But experts increasingly think of this as “more of a dynamic process,” said Natasha Mesinkovska, a dermatologist at UCI Health who has studied hair graying.

Previously, experts viewed graying as something that inevitably happened to hair with age. Newer research suggests “the pattern of pigmentation is more of a live thing than something that’s set in stone,” Mesinkovska said. This means some factors may have more influence over the graying process than you think.

You’ll probably go gray similar to the way your parents did

Genes aren’t the only influence, but they do play a major role. “In the end, that’s what’s determining when you go gray,” Cotsarelis said.

Scientists have discovered genes that seem to have a hand in hair graying and may also affect characteristics such as balding, eyebrow shape and beard thickness. There can be ethnicity differences, too. People who are White tend to go gray earlier than people of African and Asian descent, research has found, and natural blonds may experience a higher percentage of graying sooner.

Premature hair graying — which has not been clearly defined, Cotsarelis said, but is sometimes considered graying before age 20 for Whites, before age 25 for Asians and before age 30 for Black people — also seems to be influenced by genes. One variant, called IRF4, is “strongly linked to earlier graying,” Mesinkovska said. And though rare, certain inherited disorders such as Griscelli syndrome, a condition that causes pigment issues, can result in gray hair from birth.

Men and women are equally likely to go gray, but biological sex might influence where those early gray hairs appear: Men tend to gray around the sideburns and temples, while women often notice graying around the front of the head first.

Lifestyle may influence graying, too

There’s a lot experts still don’t understand about how your lifestyle might affect graying. But some studies have found certain nutritional deficiencies, such as vitamin B12 and iron, are associated with early-onset gray hair. These nutritional deficiencies would probably be severe, though, Cotsarelis said, “not something you’re likely to find too often in the U.S.”

Most people won’t need supplements, he said, but because certain mineral deficiencies have been linked to premature hair graying, it’s wise to make sure your diet checks all of your nutritional boxes.

Stress is also thought to play a role. “It’s always kind of noted that people who are under stress seem to go gray,” said Sarah Millar, a professor in the department of oncological sciences and the dermatology department at Mount Sinai.

2020 study in the journal Nature found that in mice, stress appeared to cause a loss of melanocyte stem cells. When the sympathetic nervous system, also known as the “fight or flight” response, was activated, those melanocyte stem cells seemed to “basically proliferate and differentiate and migrate away from their kind of niche home,” said Millar, who has researched melanocyte stem cells.

That study “was really the first time there’d been a mechanistic link between activation of neurons by stress and the result of hair graying,” she said. “That was very interesting.”

In another 2021 study, researchers from Columbia University Vagelos College of Physicians and Surgeons looked at individual hairs from 14 volunteers, and observed an association between graying and weeks where the participants reported higher levels of stress.

It’s not clear whether reducing stress will slow down the process, however; more research is needed. Still, “I do believe that chronic things exhaust you,” Mesinkovska said, “and that’s why mice studies show — if you bug them nonstop, it will make them go gray.”

Not smoking (a habit known to cause early graying), getting plenty of sleep, minimizing stress, and eating a healthy diet will benefit your overall well-being and possibly support the health of your hair follicles, too. “These are, in general, great habits for antiaging, and part of that involves potentially delaying the hair-graying process,” He said.

That may also include exercise — one study has linked premature graying to a sedentary lifestyle — as well as limiting your alcohol consumption.

Can we slow gray hair progression — or even reverse it?

Other than making lifestyle changes, “there isn’t really a whole lot you can do” about gray strands, Cotsarelis said, other than dyeing your hair or loving your new shade.

At least, not yet: “In the past, the field was really focused on characterizing the changes of melanocyte stem cells,” said Mayumi Ito Suzuki, a professor in the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine. “The next step is to understand how to reverse these changes to not have gray hair.”

Some experts have theorized that melanocyte stem cells might essentially become “stuck” in the wrong location during the process of regeneration. “In theory, if healthy stem cells are preserved, hair graying can be transient,” she said.

Her lab, which studies how melanocytes regenerate from stem cells, explored this idea in a 2023 Nature study. Ito’s team observed the localization pattern of stem cells in young and older mice. “If they’re located in a different place somehow during aging, they remain dormant, and don’t produce mature melanocytes,” she said, and in turn don’t produce pigment. Her team is now looking at human samples to see if relocating melanocytes can help prevent the graying process.

There are some over-the-counter topical products that claim to reverse graying, but “none of them have proven efficacy,” He said. Topicals in general are challenging because pigment-producing melanocyte stem cells are in the deepest part of the hair follicle. This is why drugs like Latisse, which do successfully lengthen and darken eyelashes, “just don’t work on the scalp,” Cotsarelis said. “The skin is too thick.”

Some research on potential new treatments “is getting a lot of attention,” Mesinkovska said. A 2023 study from the University of Miami Miller School of Medicine found topical rapamycin may help restimulate melanin. The drug, which is an immunosuppressant used to prevent organ rejection, is not approved by the Food and Drug Administration for this use and is “a fairly potent drug,” Millar cautioned.

If you think you’re experiencing early-onset gray, it’s worth consulting your doctor, Mesinkovska said. “If someone comes to me and says, ‘I have early graying,’ I look for the reason,” she said — while there isn’t always one specific cause that can be fixed, sometimes addressing nutritional deficiencies, a thyroid disorder or inflammation may help, she added.

Since every new hair cycle is an opportunity for a strand to regrow without pigment, “if you’re experiencing a lot of hair loss, you may accelerate the graying,” Cotsarelis said.

Hair loss can’t always be prevented — age, a hereditary disposition and chemotherapy are frequent culprits — but the American Academy of Dermatology recommends minimizing breakage by avoiding treatments such as perms that may damage hair, as well as hairstyles that pull at the scalp.

Stay away from tweezers while you’re at it. “There is a myth that if you pluck out gray hair you’re going to get more gray hairs — that’s not necessarily true, but it’s not an effective strategy,” He said. “More likely than not, the hair that grows out of the follicle next will be gray.”

Click here or visit https://bit.ly/4aPkpCP to read the full The Washington Post article.

Interdisciplinary Skin Science Program

Kristen Kelly, founding director

With a unique collaboration between basic and translational skin scientists, this group will develop the next generation of medications and technologies for treatment of dermatologic disease and advance skin disease diagnosis and monitoring.

UC Irvine’s Interdisciplinary Skin Science Program is one of only six National Institutes of Health-funded Skin Disease Research Core Centers nationwide and, of those, one of only three that also have NIH grants to train future leaders in the field. Its researchers are focused on a range of dermatologic issues, including cancer, inflammatory disorders like psoriasis and eczema, genetic skin disease, cell development and repair, gynecologic skin disease, alopecia (hair loss), and pigmentary disorders like vitiligo and melasma. The program is also known for its work advancing state-of-the-art, noninvasive microscopic imaging.

Now in the Falling Leaves Foundation Medical Innovation Building, seven skin science researchers – with room for one additional future hire – occupy space on the third floor, which is a big step forward for the program, according to founding director Dr. Kristen Kelly, UC Irvine professor and chair of dermatology. The new home base not only brings the skin researchers together but offers important opportunities to collaborate with other groups on the premises. Says Kelly: “It’s really a testament to UC Irvine’s commitment to progress. The impact is going to be better science, which is going to lead to better treatments for patients. I count on seeing significant advances coming from the researchers in this building.”

Click here or visit https://bit.ly/skin-science to view the full article in the Fall 2025 issue of UC Irvine Magazine, “Forging a Brilliant Future.”

OC500 2025: CHRIS BARTY

CHRIS BARTY
CO-FOUNDER/CTO
LUMITRON TECHNOLOGIES INC.
By OCBJ Staff

WHY: Co-founded Irvine-based developer pioneering an ultra-high-intensity, laser-based X-ray system called HyperVIEW for the next generation of cancer treatments.

IN THE NEWS: Lumitron’s X-ray imaging system granted designation of “Breakthrough Device” from FDA in January for its utilization of the K-Edge subtraction technique to improve contrast-enhanced imaging for detecting breast cancer.

NOTABLE: Professor of physics and astronomy at the University of California, Irvine; previously CTO at the National Ignition Facility Directorate at the Lawrence Livermore National Laboratory, where he spent 17 years inventing the core technologies upon which Lumitron’s system is based.

QUOTABLE: “Lumitron’s HyperVIEW laser-Compton X-ray source is an alternative to traditional X-ray tubes that can provide images with significantly greater clarity and accuracy. These capabilities can both enable more reliable detection and reduce the dose of radiation received by the patient.”

Click here or visit https://bit.ly/oc500-barty to read full article on the Orange County Business Journal website.